Bli medlem
Bli medlem

Du är här


New US patent approval for Episurf Medical

Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent, entitled "System and method for creating a decision support material indicating damage to an anatomical joint", relates to 3D-based assessment of joint lesions, and complements Episurf Medical's earlier US patents within this field.

"This patent gives us additional protection in the US within medical imaging and surgical pre-planning, this time with a focus on the ankle" comments Katarina Flodström, COO, Episurf Medical.  

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69

Författare Cision